Literature DB >> 17913524

Subfoveal choroidal neovascularization in a 3-year-old child with North Carolina macular dystrophy.

David Y Rhee1, Elias Reichel, Adam Rogers, Mitchell Strominger.   

Abstract

North Carolina macular dystrophy is characterized by nonprogressive atrophy of the choroid, choriocapillaris, and the retinal pigment epithelial layer. The characteristic retinal findings, ranging from scattered drusen to a posterior staphyloma, have been reported as early as infancy and usually reach their greatest magnitude in the second decade of life. Herein, we describe a case of a 3-year-old boy with a documented family history of North Carolina macular dystrophy who presented with a subfoveal choroidal neovascular membrane in addition to the macular dystrophic changes.

Entities:  

Mesh:

Year:  2007        PMID: 17913524     DOI: 10.1016/j.jaapos.2007.06.010

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  5 in total

1.  Choroidal neovascularization in 36 eyes of children and adolescents.

Authors:  P Rishi; A Gupta; E Rishi; B J Shah
Journal:  Eye (Lond)       Date:  2013-07-26       Impact factor: 3.775

2.  Choroidal neovascularization in 111 eyes of children and adolescents.

Authors:  Pukhraj Rishi; Rekha Priya Kalluri Bharat; Ekta Rishi; Muna Bhende; Jyotirmay Biswas; Arshee Ahmed; Sridharan Sudharshan
Journal:  Int Ophthalmol       Date:  2021-08-23       Impact factor: 2.031

3.  A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy.

Authors:  Shijing Wu; Zhisheng Yuan; Zixi Sun; Tian Zhu; Xing Wei; Xuan Zou; Ruifang Sui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-24       Impact factor: 3.117

4.  Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization.

Authors:  Gandra Mamatha; Vetrivel Umashankar; Nachiappan Kasinathan; Tandava Krishnan; Ravichandran Sathyabaarathi; Thirumalai Karthiyayini; John Amali; Chetan Rao; Jagadeesan Madhavan
Journal:  Mol Vis       Date:  2011-07-20       Impact factor: 2.367

5.  Ranibizumab for choroidal neovascular membrane in a rare case of Bietti's crystalline dystrophy: a case report.

Authors:  Kasinathan Nachiappan; Tandava Krishnan; Jagadeesan Madhavan
Journal:  Indian J Ophthalmol       Date:  2012 May-Jun       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.